Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
Sell
-5
Closed -$22K 4285
2015
Q3
$22K Buy
5
+1
+25% +$5.97K ﹤0.01% 4222
2015
Q2
$25K Buy
+4
New +$28.4K ﹤0.01% 4497
2015
Q1
Sell
-5
Closed -$29K 4472
2014
Q4
$29K Buy
+5
New +$34.7K ﹤0.01% 4536
2014
Q3
Sell
-9
Closed -$90K 4537
2014
Q2
$90K Buy
9
+5
+125% +$44.6K ﹤0.01% 4552
2014
Q1
$38K Sell
4
-3
-43% -$31.2K ﹤0.01% 4593
2013
Q4
$69K Buy
7
+6
+600% +$71.9K ﹤0.01% 4508
2013
Q3
$13K Sell
1
-3
-75% -$44.3K ﹤0.01% 4182
2013
Q2
$52K Buy
+4
New +$55.7K ﹤0.01% 4092

Other funds holding IMNN

Credit Suisse's IMNN Position: Q4 2015 in Review

Credit Suisse sold out of Imunon (IMNN) in Q4 2015, closing a stake of 5 shares — an estimated $22K sold.

Credit Suisse first reported a position in IMNN in Q2 2013 and held it in 8 quarters. The position peaked at $90K in Q2 2014. 25 funds tracked by Wall St. Rank hold IMNN as of Q4 2015.

  • Credit Suisse reported no remaining Imunon position as of Q4 2015 after selling out during the quarter.
  • Credit Suisse sold 5 Imunon shares in Q4 2015, an estimated $22K.
  • Credit Suisse first reported a position in Imunon in Q2 2013 and held it in 8 quarters.
  • Credit Suisse's Imunon position peaked at $90K in Q2 2014.
  • 25 funds tracked by Wall St. Rank held Imunon as of Q4 2015.

Based on Credit Suisse's 13F filing for Q4 2015, filed 16 Feb 2016.